Seeking Alpha

Dendreon (DNDN +1.1%) sells its immunotherapy manufacturing facility in Morris Plains, New...

Dendreon (DNDN +1.1%) sells its immunotherapy manufacturing facility in Morris Plains, New Jersey, to Novartis (NVS) for $43M in cash. The sale is part of Dendreon's restructuring plans on "its path to profitability and future growth." The plant was used to manufacture cancer drug Provenge, which has had its marketing troubles.
From other sites
Comments (1)
  • vtstuart
    , contributor
    Comments (124) | Send Message
     
    Lower expenses, plus cash - a step in the right direction.
    20 Dec 2012, 10:13 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs